Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008816 |
YEM_ID: | YEM-60 |
XU_ID: | XU-35 |
ID: | TCMBANKHE008816/YEM-60/XU-35 |
植物拉丁名: |
|
功能与主治: | To astringe intestines and check diarrhea, resolve toxin, relieve itch./Diarrhea, dysentery, leprosy, scrotal wind, itchy skin. |
药用植物名: | 胡桃树皮|胡桃|核桃树根 |
药名: | 核桃 |
来源: | 云南民族药物志：第一卷|云南省楚雄彝族自治州永仁县永仁古镇农贸市场 |
药用部位: | bark|根 |
使用民族: | 阿昌族/傣族/德昂族/哈尼族/景颇族/傈僳族/彝族/藏族 |
KUMST_ID1: | KUMST-BS-0037 |
KUMST_ID2: | KMUST-20180729030 |
TCM_ID_id: | 6086 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000101 | juglone | Nucin; Iuglon; AIDS-005215; Spectrum2_000778; Spectrum3_001228; HMS503M13; DB-005382; KBio2_007606; cMAP_000058; UNII-W6Q80SK9L6; Antibiotic PD7; NCGC00095247-05; SCHEMBL34185; KBioGR_000497; KBio2_000497; AC1L1GR8; Walnut extract; NSC153189; 5-hydroxy-1,4-naphtoquinone; 1,4-Naphthalenedione,5-hydroxy-; HMS3403I19; HMS1990I19; MFCD00001684; KBio3_000913; BG01503871; QC-1358; Caswell No. 515AA; IN1286; AC1Q6B0X; 5-hydroxy-1,4-dihydronaphthalene-1,4-dione; RTR-030750; NSC-153189; BSPBio_001157; AB0019716; HMS1362I19; SPBio_000856; NSC 622948; Regianin; AIDS005215; KQPYUDDGWXQXHS-UHFFFAOYSA-N; AC1Q794F; 5-Hydroxy-1,4-naphthosemiquinone; NCGC00095247-01; 5-Hydroxy-1,4-naphthoquinone; V0179; SPECTRUM300038; Bio1_000441; C.I. Natural Brown 7; KBio3_000914; H47003_ALDRICH; 5-hydroxy-1,4- naphthalenedione; ST5330598; LS-2142; Akhnot; MolPort-000-725-926; 8-Hydroxy-1,4-naphthalenedione; BDBM24777; SMP1_000168; KBio2_003065; WLN: L66 BV EVJ GQ; KBio2_002470; NCI 2323; 1,4-NAPHTHALENEDIONE, 5-HYDROXY-; C.I. 75500; KBioSS_000497; juglone ; 5-Hydroxy-1,4-naphthalenedione; KBio3_002176; KBio2_003463; Juglane; KBio2_005633; D0C0NH; KS-0000195Q; Bio2_000409; 5-Hydroxy-[1,4]Naphthoquinone; 5-Hydroxy-1,4-naphthoquinone, 97%; Spectrum5_000357; Bio1_000930; KBio1_001026; NCGC00095247-03; 5-Hydroxy-1,4-naphthalenedione, 9CI; 5-Hydroxy-p-naphthoquinone; KBio2_005038; EINECS 207-567-5; 1,4-dihydro-1,4-dioxo-5-hydroxynaphthalene; 5-Hydroxynaphthalene-1,4-dione; D02FPF; 5-HNQ; Walnut Extract; CCG-40256; AN-23490; IDI1_002164; CHEBI:15794; AM20040546; KBioGR_002257; 5-hydroxy-naphthalene-1,4-dione; ZINC00526257; CHEMBL43612; 5-Hydroxy-1,4-naftochinon [Czech]; NCGC00095247-04; 1, 8-hydroxy-; KB-73530; 5-Hydroxy-1,4-naftochinon; HMS1792I19; J-650071; CTK8B1734; 1,4-Naphthoquinone, 5-hydroxy-; FCH1114383; ACN-049171; W6Q80SK9L6; NSC-34266; NSC622948; IDI1_001026; Juglon; Oil Red BS; Avastin+/-Tarceva; Q-100522; BSPBio_002676; NCGC00095247-02; DTXSID0031504; C-05811; DivK1c_001026; 1,4-Naphthoquinone, 5-hydroxy- (8CI); SDCCGMLS-0066542.P001; C03840; 5-Hydroxy-1,4-naphthlenedione; 3b7j; KBio2_006031; ANW-30636; AKOS001576598; F0451-0746; KBioGR_002470; JUG; 1,4-Naphthalenedione, 5-hydroxy-; HMS1923G07; I14-6718; NSC 153189; CC-21839; Spectrum_000415; InChI=1/C10H6O3/c11-7-4-5-9(13)10-6(7)2-1-3-8(10)12/h1-5,12; Jugnlon; KBioSS_002477; ACM481130; 59990_FLUKA; AK307307; CCRIS 5423; ZB014304; Yuglon; ZINC526257; KBio2_000895; 5-Hydroxynaphthoquinone; KBioSS_000895; D08PZH; 4-08-00-02368 (Beilstein Handbook Reference); KBio3_002948; NINDS_001026; BRN 1909764; Bio1_001419; NSC-622948; SR-05000002406-1; 5-hydroxy-1,4-naphthoquinone; MCULE-5238429657; 8-Hydroxy-1,4-naphthoquinone; Juglone; NSC34266; FT-0627559; 481-39-0; 1,4-Naphthoquinone, 8-hydroxy-; ACMC-1AFTN; CI 75500; Bio2_000889; Spectrum4_001769; SR-05000002406; 5-hydroxy-1,4-naphthoquinone, 4; ST50330598 | C10H6O3 | 174.15 | C1=CC2=C(C(=O)C=CC2=O)C(=C1)O |
| TCMBANKIN000649 | (S)-(8E, 10E)-12-hydroxy-7-oxo-8,10-octadecadienoic acid methyl ester | ||||
| TCMBANKIN004717 | Jugnaphthalenoside A | C23H20O12 | 488.4 g/mol | C1=CC2=C3C(=CC(=C2C(=C1)O)OC4C(C(C(C(O4)CO)O)O)O)C5=C(C(=C(C=C5C(=O)O3)O)O)O | |
| TCMBANKIN006172 | methyl(7E,9E)-6,11-dioxononadeca-7,9-dienoate | ||||
| TCMBANKIN006176 | Jugnaphthalenoside C | C30H24O16 | 640.5 g/mol | C1=CC2=C3C(=CC(=C2C(=C1)O)OC4C(C(C(C(O4)COC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)O)C6=C(C(=C(C=C6C(=O)O3)O)O)O | |
| TCMBANKIN012269 | (S)-(8E,10E)-12-hydroxy-7-oxo-8,10-octadecadienoic acid | C18H30O4 | CCCCCCC(C=CC=CC(=O)CCCCCC(=O)O)O | ||
| TCMBANKIN030890 | 3,4,5,6-tetrahydroxy-1,8-naphalic anhydride | ||||
| TCMBANKIN033350 | Jugnaphthalenoside B | C29H30O16 | 634.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C4C(=C5C(=C3)C6=C(C(=C(C=C6C(=O)O5)O)O)O)C=CC=C4O)O)O)O)O)O)O | |
| TCMBANKIN040269 | myricitrin | 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; Myricetin 3-O-rhamnoside; 17912-87-7; Myricetrin; 5,7-dihydroxy-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-2-(3,4,5-trihydroxyphenyl)-4-chromenone; MLS000574998; Myricetin 3-O-alpha-L-rhamnopyranoside; 3,3',4',5,5',7-Hexahydroxyflavone 3-O-Rhamnoside; Myricitrin (8CI); AIDS-011946; M2361; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; NCGC00163596-01; Myricitrin; Myricetin 3-O-alpha-L-rhamnoside; NSC 19803; 5,7-Dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-(3,4,5-trihydroxy-phenyl)-1-benzopyran-4-one; MEGxp0_000257; C10108; myricetin-3-O-rhamnose; ACon1_000103; SCHEMBL226023; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromone; SMR000232363; AIDS011946; EINECS 241-856-7; LMPK12112436; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | C21H20O12 | 464.376 | c1(O[H])c([H])c(C2=C(O[C@]3([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O2)c([H])c(O[H])c1O[H] |
| TCMBANKIN045030 | 3,6-dihydroxy-p-menth-1-ene | C10H18O2 | 170.249 | C1([H])=C(C([H])([H])[H])[C@]([H])(O[H])C([H])([H])[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])[C@]1([H])O[H] | |
| TCMBANKIN058069 | 1,2,3,6-Tetragalloylglucose | [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxyphenyl)carbonyloxy]-6-[(3,4,5-trihydroxyphenyl)carbonyloxymethyl]oxan-4-yl] 3,4,5-trihydroxybenzoate; 79886-50-3; 1,2,3,6-Tetra-O-galloyl-B-D-glucose; 1,2,3,6-Tgg; beta-D-Glucopyranose, 1,2,3,6-tetrakis(3,4,5-trihydroxybenzoate); 1,2,3,6-tetrakis-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranose; 3,4,5-trihydroxybenzoic acid [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[oxo-(3,4,5-trihydroxyphenyl)methoxy]-6-[[oxo-(3,4,5-trihydroxyphenyl)methoxy]methyl]-4-tetrahydropyranyl] ester; AIDS-070890; 1,2,3,6-Tetra-O-galloyl-beta-D-glucose; [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxybenzoyl)oxy]-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-4-yl] 3,4,5-trihydroxybenzoate; MEGxp0_001175; CHEBI:17527; AIDS070890; [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxybenzoyl)oxy]-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxan-4-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2S,3R,4S,5R,6R)-5-hydroxy-2,3-bis[(3,4,5-trihydroxybenzoyl)oxy]-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-4-yl] ester; C04516; 1,2,3,6-Tetrakis-O-galloyl-beta-D-glucose; ACon1_000379; 1,2,3,6-tetragalloylglucose; 1,2,3,6-tetra-O-galloyl-β-D-glucose; 1,2,3,6-tetra-O-galloyl-β-D-glucopyranose; 1,2,3,6-Tetragalloylglucose; 1,2,3,6-tetra-o-galloyl-beta-d-glucopyranoside; 1,2,3,6-tetra-o-galloyl-beta-d-glucose; 1,2,3,6-tetra-o-galloyl-β-d-glucose; 1, 2, 3, 6-tetra-o-galloyl-beta-d-glucopyranoside | C34H28O22 | 788.6 g/mol | C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)O |
| TCMBANKIN058151 | taxifolin | (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4-chromanone; (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone; (2R,3R)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 20254-28-8 (DELETED); trans-Dihydroquercetin; ()-Taxifolin; Taxifolin; ZINC00105077; CHEBI:17948; AIDS003061; MEGxp0_000741; 17654-26-1 (DELETED); 3,3′,4′,5,7-Pentahydroxyflavanone; (+)-Taxifolin; MLS000759539; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-one; (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE; 78666_FLUKA; MLS001074712; STOCK1N-51590; DQH; T4512_SIGMA; TAXIFOLIN-(+); (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one; ACon1_000239; (+)-Dihydroquercetin; SMR000466389; 480-18-2; C01617; (2R,3R)-TRANS-DIHYDROQUERCETIN; MLS001066341; AIDS-003061; MLS000759526; AC1LEHLM; NC00093; TAXIFOLIN-(+/-); SCHEMBL1707803; ZINC105086; MLS001423978; (?)-Epitaxifolin; ZB003534; CHEMBL221328; (2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one; (2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one; Dihydro quercetin; SMR000499525; CCG-100843; CPD000499525; CHEBI:75747; (-)-epitaxifolin; SAM001246760; AB00698321-05; AJ-11152; HMS2051I06; dihydroquercetin ; (2R,3S)-epitaxifolin; MLS000759526; dihydroquercetin | C15H12O7 | 304.25 g/mol | C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O |
| TCMBANKIN058574 | (?)-regiolone | (4r)-4,8-dihydroxy-α-tetralone | C10H10O3 | 178.18 g/mol | C1CC(=O)C2=C(C1O)C=CC=C2O |
| TCMBANKIN060160 | quercitrin | C21H20O11 | 448.4 g/mol | CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O | |
| TCMBANKIN060161 | afzelin | C21H20O10 | 432.4 g/mol | CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab